SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Life Sciences informs about clarification

11 Oct 2021 Evaluate
Suven Life Sciences has informed that the company has been notifying NSE & BSE all the information which comes under the purview of Regulation 30 of SEBI (LODR) Regulations, 2015 from time to time. At this point of time the Company does not have any material announcement/ event due for notification to the stock exchanges under Regulation 30 of SEBI LODR Regulations which may have a bearing on the price behaviour of the scrip. The increase in the price of its security in the recent past appears to be based on market speculation and it has no other comment to offer on this development. 

The above information is a part of company’s filings submitted to BSE.

Suven Life Sciences Share Price

195.90 -0.10 (-0.05%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×